منابع مشابه
Human hematopoietic progenitors express erythropoietin.
Erythropoietin (EPO) is a factor essential for erythroid cell proliferation, differentiation, and survival. The production of EPO by the kidneys in response to hypoxia and anemia is well documented. To determine whether EPO is also produced by hematopoietic cells, we analyzed the expression of EPO in normal human hematopoietic progenitors and in their progeny. Undifferentiated CD34(+)lin- hemat...
متن کاملBrain Repair by Endogenous Progenitors
Stem cells within the adult brain can be stimulated by injury and growth factor treatment to replace damaged neurons, even neurons that are not normally generated in adults. Coupled with recent insights into the mechanism by which Nogo inhibits axonal regeneration, this discovery may inspire new treatments for central nervous system injuries and neurodegenerative diseases.
متن کاملNeural progenitors for sensory and motor repair
Hoeber, J. 2017. Neural progenitors for sensory and motor repair. Digital Comprehensive Summaries of Uppsala Dissertations from the Faculty of Medicine 1365. 67 pp. Uppsala: Acta Universitatis Upsaliensis. ISBN 978-91-513-0058-0. Injury and neurodegenerative conditions of the spinal cord can lead to paralysis and loss of sensation. Cell therapeutic approaches can restore sensory innervation of ...
متن کاملStem cells, progenitors and myelin repair.
Remyelination, the process by which new myelin sheaths are restored to demyelinated axons, represents one of the most compelling examples of adult multipotent progenitor cells contributing to regeneration of the injured central nervous system (CNS). This process can occur with remarkable efficiency in both clinical disease, such as multiple sclerosis, and in experimental models, revealing an im...
متن کاملErythropoietin: repair of the failing heart.
yocardial infarction (MI) and subsequent loss of contracile myocardium is a frequent cause of chronic heart failure CHF). In the Framingham population, MI accounts for 4% cases of CHF in men and 13% in women (1). This ercentage may even increase in the future because imroved post-MI survival may contribute to increasing prevlence of CHF. Evidence-based treatment of CHF is ocused on suppressing ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Kidney International
سال: 2007
ISSN: 0085-2538
DOI: 10.1038/sj.ki.5002483